For the last 25 years or so, the availability of a mouse model with a targeted replacement of mouse Apoe gene (Sullivan et al., 1997) provided an opportunity to address a myriad of questions ranging from the role of APOE isoforms in AD pathogenesis to how successful variety of therapeutic strategies have been so far. The gene discussed is APOE; the disease is Alzheimer disease.